Stock Research for ONTX

ONTX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ONTX Stock Chart & Research Data

The ONTX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ONTX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ONTX Due diligence Resources & Stock Charts

The ONTX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ONTX Detailed Price Forecast - CNN Money CNN View ONTX Detailed Summary - Google Finance
Yahoo View ONTX Detailed Summary - Yahoo! Finance Zacks View ONTX Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ONTX Trends & Analysis - Trade-Ideas Barrons View ONTX Major Holders - Barrons
NASDAQ View ONTX Call Transcripts - NASDAQ Seeking View ONTX Breaking News & Analysis - Seeking Alpha
Spotlight View ONTX Annual Report - CompanySpotlight.com OTC Report View ONTX OTC Short Report - OTCShortReport.com
TradeKing View ONTX Fundamentals - TradeKing Charts View ONTX SEC Filings - Bar Chart
WSJ View Historical Prices for ONTX - The WSJ Morningstar View Performance/Total Return for ONTX - Morningstar
MarketWatch View the Analyst Estimates for ONTX - MarketWatch CNBC View the Earnings History for ONTX - CNBC
StockMarketWatch View the ONTX Earnings - StockMarketWatch MacroAxis View ONTX Buy or Sell Recommendations - MacroAxis
Bullish View the ONTX Bullish Patterns - American Bulls Short Pains View ONTX Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ONTX Stock Mentions - StockTwits PennyStocks View ONTX Stock Mentions - PennyStockTweets
Twitter View ONTX Stock Mentions - Twitter Invest Hub View ONTX Investment Forum News - Investor Hub
Yahoo View ONTX Stock Mentions - Yahoo! Message Board Seeking Alpha View ONTX Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ONTX - SECform4.com Insider Cow View Insider Transactions for ONTX - Insider Cow
CNBC View ONTX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ONTX - OTC Markets
Yahoo View Insider Transactions for ONTX - Yahoo! Finance NASDAQ View Institutional Holdings for ONTX - NASDAQ


Stock Charts

FinViz View ONTX Stock Insight & Charts - FinViz.com StockCharts View ONTX Investment Charts - StockCharts.com
BarChart View ONTX Stock Overview & Charts - BarChart Trading View View ONTX User Generated Charts - Trading View




Latest Financial News for ONTX


Traws Pharma Full Year 2023 Earnings: Beats Expectations
Posted on Thursday April 04, 2024

Traws Pharma ( NASDAQ:TRAW ) Full Year 2023 Results Key Financial Results Net loss: US$18.9m (flat on FY 2022). US$0.90...


Traws Pharma Announces New Employee Inducement Grants
Posted on Tuesday April 02, 2024

NEWTOWN, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (Nasdaq: TRAW, “Traws”, the “Company”) today announced it has granted equity awards to new employees who joined Traws in connection with the recent acquisition of Trawsfynydd Therapeutics, Inc. by Onconova Therapeutics, Inc. (the “Merger”). On April 1, 2024, Traws granted restricted stock equity awards to Werner Cautreels, Iain Dukes, Nikolay Savchuk, C. David Pauza and Robert Redfield, as an inducement for each of them to accep


Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company
Posted on Tuesday April 02, 2024

Closing cash balance of approximately $28 million expected from concurrent private placement led by OrbiMed and Torrey PinesFunding expected to advance development of three potential best-in-class/class leading assets: viroksavir, a cap-dependent endonuclease inhibitor for influenza; travaltrelvir, a protease inhibitor for COVID19; and narazaciclib, a next generation CDK4/6 inhibitor for low grade endometriod endometrial cancer (LGEEC)Multiple near-term catalysts, for viroksavir and travaltrevir


We Think Onconova Therapeutics (NASDAQ:ONTX) Needs To Drive Business Growth Carefully
Posted on Saturday March 09, 2024

Just because a business does not make any money, does not mean that the stock will go down. For example, although...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.